SCHEMBL797349

SCHEMBL797349

CCCc1c(CCC)c(CCC)c2c(c1CCC)Cc1c(c(CCC)c(C(=O)OC)c(C(=O)OC)c1CCC)C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 2/20 0.39
CNR2 P34972 2/20 0.39
MAPK1 P28482 3/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 4/20 0.35
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10079132 0.90 CNR2 (0.37) CNR1CNR2MAPK1HPGDMEN1
SCHEMBL796741 0.90 NPC1 (0.39) CNR1CNR2MAPK1HPGDL3MBTL1
SCHEMBL796709 0.88 MEN1 (0.39) CNR1CNR2MAPK1HPGDMEN1
SCHEMBL796328 0.84 KDM4E (0.40) MAPK1HPGDMEN1KMT2AATM
SCHEMBL797878 0.82 CNR2 (0.44) CNR1CNR2MAPK1HPGDMAPT
SCHEMBL10079139 0.82 MEN1 (0.38) CNR1CNR2MAPK1HPGDMEN1
SCHEMBL13815353 0.81 MEN1 (0.37) CNR1CNR2MAPK1HPGDMEN1
SCHEMBL10079115 0.80 NPC1 (0.38) CNR1CNR2MAPK1HPGDL3MBTL1
SCHEMBL796776 0.79 LDHA (0.44) L3MBTL1
SCHEMBL797846 0.78 LMNA (0.37) CNR1CNR2MAPK1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1262469-B1 POLYACENE DERIVATIVES AND PRODUCTION THEREOF JAPAN SCIENCE & TECH AGENCY (JP) 2012-01-11 EP disclosed
US-7901594-B2 Electroconductivity JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2011-03-08 US disclosed
US-20030116755-A1 Polyacene derivatives and production thereof JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) 2003-06-26 US disclosed
EP-1262469-A1 POLYACENE DERIVATIVES AND PRODUCTION THEREOF Japan Science and Technology Corporation (JP) 2002-12-04 EP disclosed
JP-2000026339-A MULTIPLY SUBSTITUTED CONDENSED POLYCYCLIC COMPOUND AND ITS PRODUCTION TAKAHASHI TAMOTSU 2000-01-25 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030116755-A1 Polyacene derivatives and production thereof CBR1, HVCN1, H1-0 CNR1 492/4885CNR2 1020/4885MAPK1 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.